Skip to main content
Top

BMC Endocrine Disorders

2001 - 2024
Volumes
28
Issues
Chevron right icon
Issue 1/2024
Latest issue

About this journal

Dedicated to cover all aspects of research into conditions related to the endocrine system including the prevention, diagnosis and management, BMC Endocrine Disorders is a well-established open access peer-reviewed journal. Authors benefit from a fast turnaround time between acceptance and publication, an international Editorial Board and a wide journal readership. This journal is part of the BMC series, a collection of journals that are focused on individual research communities, publishing all scientifically valid studies based on community-aligned standards of questioning, methods and analysis.

Metadata
Title
BMC Endocrine Disorders
Coverage
Volume 1/2001 - Volume 24/2024
Publisher
BioMed Central
Electronic ISSN
1472-6823
Journal ID
12902
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare